Literature DB >> 15048134

Vascular factors altered in glucose-treated mesangial cells and diabetic glomeruli. Changes in vascular factors impair endothelial cell growth and matrix.

Ashok K Singh1, Krishnamurthy P Gudehithlu, Alfredo A Pegoraro, Gogi K Singh, Khaja Basheerudin, Robert B Robey, Jose A L Arruda, George Dunea.   

Abstract

We studied the effect of a high glucose (HG) environment on the vascular factors that are secreted by mesangial cells, and regulate endothelial growth and mesangial matrix deposition. To this effect, we measured the vascular factors in the glomeruli of streptozotocin-induced diabetic kidneys and in mesangial cells exposed to a HG concentration. We then transferred the media of mesangial cells previously exposed to high glucose to cultured endothelial cells to study the effects on endothelial growth, matrix formation, and in vitro capillary proliferation. In 1-week diabetic kidneys, glomerular vascular endothelial growth factor (VEGF) and angiopoietin-1 were inhibited by 38 and 57%, respectively, but angiopoietin-2 was increased by 318%. We found similar results in mesangial cells exposed to HG. There was a decrease of VEGF (50% by enzyme immunoassay, 27% by mRNA), decrease of angiopoietin-1 (65% by mRNA), and a much greater increase of angiopoietin-2 (280% by immunoassay, 523% by mRNA). Compared to controls, the media of mesangial cells previously exposed to HG impaired endothelial cell growth by 61%, increased extracellular matrix by 100%, and decreased capillary formation by 90%. We conclude that high ambient glucose alters the secretion of vascular factors elaborated by mesangial cells, resulting in an expansion of the endothelial cell matrix and disruption of capillary structure.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15048134     DOI: 10.1038/labinvest.3700082

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  7 in total

1.  A potential pathological role of angiopoietins expression in glomeruli during progressive glomerulisclerosis related to podocyte injury.

Authors:  Yuanhang Lu; Anguo Deng; Xiao Yang; Jianshe Liu; Zhonghua Zhu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2006

Review 2.  Vascular endothelial growth factor and diabetic nephropathy.

Authors:  Sheldon Chen; Fuad N Ziyadeh
Journal:  Curr Diab Rep       Date:  2008-12       Impact factor: 4.810

Review 3.  Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis.

Authors:  Vivette D D'Agati; Avry Chagnac; Aiko P J de Vries; Moshe Levi; Esteban Porrini; Michal Herman-Edelstein; Manuel Praga
Journal:  Nat Rev Nephrol       Date:  2016-06-06       Impact factor: 28.314

4.  Insulin directly stimulates VEGF-A production in the glomerular podocyte.

Authors:  L J Hale; J Hurcombe; A Lay; B Santamaría; A M Valverde; M A Saleem; P W Mathieson; G I Welsh; R J Coward
Journal:  Am J Physiol Renal Physiol       Date:  2013-05-22

5.  Disruption of Ang-1/Tie-2 signaling contributes to the impaired myocardial vascular maturation and angiogenesis in type II diabetic mice.

Authors:  Jian-Xiong Chen; Amanda Stinnett
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-06-12       Impact factor: 8.311

6.  Effects of extremely low frequency pulsed magnetic fields on diabetic nephropathy in streptozotocin-treated rats.

Authors:  Feijiang Li; Tao Lei; Kangning Xie; Xiaoming Wu; Chi Tang; Maogang Jiang; Juan Liu; Erping Luo; Guanghao Shen
Journal:  Biomed Eng Online       Date:  2016-01-19       Impact factor: 2.819

7.  Activation of endothelial NAD(P)H oxidase accelerates early glomerular injury in diabetic mice.

Authors:  Hajime Nagasu; Minoru Satoh; Emi Kiyokage; Kengo Kidokoro; Kazunori Toida; Keith M Channon; Yashpal S Kanwar; Tamaki Sasaki; Naoki Kashihara
Journal:  Lab Invest       Date:  2015-11-09       Impact factor: 5.662

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.